Moneycontrol > News > Business

IST

Novartis - develop & commercialize glaucoma treatment

Novartis reaches agreement to develop and commercialize glaucoma treatment with novel mechanism of action

Source: Moneycontrol.com
Share Share on Tumblr
Share  .  Email  .  Print  .  A+

Set email alert for

Tags: Novartis , agreement , commercialize glaucoma treatment , novel mechanism , action, Japan, Rho Kinase inhibitor , Senju Pharmaceutical , glaucoma
Online fraud: Why should you not blame banks
LG showcases 5-inch HD, TFT Oxide display at SID Display Week
Was London's brutal attack really terrorism? "Was London's brutal attack really terrorism?"
Suspecting wife, man kills three children, self in UP
Bhaag Milkha Bhaag: New promo shows Milkha's soft side

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

May 23 2013, 10:43

Lower Re fails to deter FIIs; mkt stable on inflows: Dalal

- in MARKET OUTLOOK

May 23 2013, 09:33

Mkt headed lower; time to sell in May and go away: Sukhani

- in Technicals

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window